AI-Aided Design of Novel Inhibitors Against SARS-CoV-2
Offered By: Toronto Machine Learning Series (TMLS) via YouTube
Course Description
Overview
Explore the cutting-edge application of artificial intelligence in drug discovery for COVID-19 treatment in this 36-minute conference talk by Dr. Dong Xu at the Toronto Machine Learning Series. Learn about the development of a novel advanced deep Q-learning network combined with fragment-based drug design to generate potential lead compounds targeting the SARS-CoV-2 3C-like main protease (3CLpro or Mpro). Discover how this AI-driven approach addresses the urgent need for new chemical entities after the failure of drug repurposing efforts. Gain insights into the structure-based optimization policy used to obtain derivatives from lead compounds and access the resulting molecular library of 47 AI-generated lead compounds and related derivatives. Understand the extension of this method to design peptide-based drugs against SARS-CoV-2, offering valuable resources for researchers in the development of potential COVID-19 treatments.
Syllabus
Dr. Dong Xu - AI-aided design of novel inhibitors against SARS-CoV-2
Taught by
Toronto Machine Learning Series (TMLS)
Related Courses
Drug DiscoveryUniversity of California, San Diego via Coursera 新药发现和药物靶点 | Drug Discovery and its Target
Peking University via edX Principles and Applications of NMR Spectroscopy
Indian Institute of Science Bangalore via Swayam Cell Culture Technologies
Indian Institute of Technology Kanpur via Swayam Medicinal Chemistry
Indian Institute of Technology Madras via Swayam